Litcius/Paper detail

Dual-targeted delivery of doxorubicin by mesoporous silica nanoparticle coated with AS1411 aptamer and RGDK-R peptide to breast cancer in vitro and in vivo

Yeganeh Hazeri, Ali Samie, Mohammad Ramezani, Mona Alibolandi, Elnaz Yaghoobi, Sadegh Dehghani, Reza Zolfaghari, Fatemeh Khatami, Taraneh Sadat Zavvar, Morteza Alinezhad Nameghi, Khalil Abnous, Seyed Mohammad Taghdisi

2022Journal of Drug Delivery Science and Technology39 citationsDOI

Topics & Concepts

DoxorubicinIn vivoAptamerMesoporous silicaBreast cancerDrug deliveryCancer cellIn vitroPharmacologyDoxorubicin HydrochlorideCancerMaterials scienceCancer researchBreast cancer chemotherapyNanotechnologyChemotherapyChemistryMedicineBiochemistryBiologyMolecular biologyMesoporous materialInternal medicineBiotechnologyCatalysisNanoparticle-Based Drug DeliveryPeptidase Inhibition and AnalysisAdvanced biosensing and bioanalysis techniques
Dual-targeted delivery of doxorubicin by mesoporous silica nanoparticle coated with AS1411 aptamer and RGDK-R peptide to breast cancer in vitro and in vivo | Litcius